Sleep Aid Composition with Dual-Phase Melatonin Release

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

A significant portion of North American adults suffer from sleep deprivation, which affects various bodily systems, including cognition, metabolism, and heart health, necessitating the development of compositions that support and improve sleep.

Innovation Solution

Sleep aid compositions comprising melatonin, L-theanine, GABA, and ashwagandha extract, formulated for rapid and sustained release, to enhance relaxation, reduce stress, and improve sleep quality.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Speed

If melatonin is released rapidly, then sleep onset is accelerated, but sleep duration is reduced

Engineering Contradiction:
Improvesleep onset speedVSAvoidsleep duration
Core Design Contradiction:
SpeedVSDuration of action of moving object

Solution Approach 1:

The melatonin is divided into two release phases: a rapid-release portion (20-60% w/w) that dissolves quickly to accelerate sleep onset, and a sustained-release portion (40-80% w/w) that dissolves slowly to maintain sleep duration. This segmentation of release kinetics resolves the contradiction between fast sleep onset and prolonged sleep duration.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The composition implements periodic release of melatonin with distinct phases: an initial rapid-release phase followed by a sustained-release phase. This periodic action pattern ensures both quick sleep onset and extended sleep maintenance without requiring separate dosing.

Inventive Principle:
Principle #19Periodic action

2Reliability

If multiple active ingredients are combined, then sleep quality is improved, but formulation complexity increases

Engineering Contradiction:
Improvesleep qualityVSAvoidformulation complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

Four active ingredients (melatonin, L-theanine, GABA, and ashwagandha extract) are merged into a single oral composition with unified release characteristics. This combination approach improves overall sleep quality by addressing multiple physiological pathways while maintaining a simple single-dose formulation that reduces complexity compared to multiple separate products.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

Each ingredient serves multiple functions: melatonin regulates circadian rhythm and promotes sleep onset, L-theanine reduces anxiety and promotes relaxation, GABA enhances sleep depth and duration, and ashwagandha reduces stress. This multi-functionality within a single composition improves comprehensive sleep quality without requiring multiple separate interventions.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Data Source

PatentUS20250302906A1Sleep aid compositions
Publication Date: 2025.10.02 MELALEUCA INC
  • US20250302906A1 patent drawing

AI summary

Sleep aid compositions are described herein. For example, this document provides sleep aid compositions containing melatonin, L-theanine, GABA (gamma-aminobutyric acid), and ashwagandha. Such compositions may be used to increase relaxation, feel relaxed more quickly, reduce stress, fall asleep, and/or stay asleep.